* Orthofix Medical Inc reported quarterly adjusted earnings of 5 cents per share for the quarter ended in January, higher than the same quarter last year, when the company reported EPS of 2 cents. The mean expectation of five analysts for the quarter was for a loss of 19 cents per share. Wall Street expected results to range from -23 cents to -13 cents per share.
* Revenue rose 6.2% to $198.62 million from a year ago; analysts expected $195.23 million.
* Orthofix Medical Inc's reported EPS for the quarter was a loss of 88 cents.
* The company reported a quarterly loss of $33.44 million.
* Orthofix Medical Inc shares had risen by 10.0% this quarter and gained 8.2% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by about 5.1% in the last three months.
* In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Orthofix Medical Inc is $20.00 This summary was machine generated from LSEG data August 6 at 01:52 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.19 0.05 Beat
Mar. 31 2024 -0.33 0.11 Beat
Dec. 31 2023 -0.08 0.02 Beat
Sep. 30 2023 -0.21 0.07 Beat
Comments